Home Blog Page 740

OneBullEx Launches AI-Native Futures Infrastructure Platform, Integrating Quantitative Research Tools and Systematic Execution Architecture for the Crypto Derivatives Market

By
Advertorial Desk
-

HONG KONG, March 27, 2026 /PRNewswire/ — 

Introduction

A new shift is taking shape in crypto trading. By embedding AI-driven research and validation tools into exchange-level infrastructure, platforms such as OneBullEx are beginning to define a new kind of technical architecture for the crypto derivatives era. It signals a broader transition in how crypto platforms are built, where intelligence, execution, and system-level efficiency are becoming as important as market access itself.

 Blockchain originally promised ownership, but in crypto futures, that promise was diluted. Participants may have access to markets, yet they often lack visibility into how strategies are validated, how performance is measured, and how execution pipelines operate. That gap between market access and operational transparency is one of the deeper tensions driving the evolution of exchange infrastructure today.

AI reshapes crypto futures infrastructure

Unlike stocks, cryptocurrency markets never close. Bots operate continuously, scanning decentralized finance (DeFi) protocols, social media and news to act within seconds. Coincub estimates that 70% of global trading volume is now executed by algorithms, primarily institutional bots. The quality of data feeding these systems matters as much as speed. Nasdaq’s AI‑driven M‑ELO order type, which uses reinforcement learning to adjust a hidden order’s hold period in real time, increased fill rates by 20.3% and reduced price mark‑outs by 11.4% compared with static parameters.

 The growth of AI-driven trading infrastructure is also changing the architecture of crypto exchanges themselves. Rather than positioning itself broadly, OneBullEx is focusing on a narrower category as a futures-first platform where AI underpins the technical architecture from the ground up. Futures remain the core strategic priority, and the exchange provides a unified environment for quantitative research, strategy validation, and deployment.

 The OneBullEx ecosystem combines three layers of functionality within a single platform. The exchange infrastructure provides the settlement and execution foundation. 300 SPARTANS operates as a systematic execution layer where rules-based programs, each having passed walk-forward testing before deployment, run continuously according to predefined parameters. OneALPHA functions as a quantitative research pipeline that converts natural-language strategy hypotheses into structured, backtested code through a five-agent workflow.

“The structural challenge in crypto futures infrastructure has always been that quantitative research tools and accessible interfaces pull in opposite directions,” said a OneBullEx representative. “We built OneALPHA and 300 SPARTANS into the exchange architecture so that the research-to-deployment pipeline lives in one environment. That integration is what defines the platform’s technical approach.”

Generational adoption and behavioural shifts

A report based on data from the MEXC exchange found that 67% of Gen Z traders activated at least one AI‑powered trading bot in Q2 2025. Younger traders treat bots as volatility management tools: 73% enable bots during market uncertainty and disable them in calmer periods. The report noted that rule-based execution reduced panic-driven exits by 47% compared with manual approaches, as predefined parameters removed the emotional variable from the process.

Yet AI trading is not a panacea. Coincub warns that most profits still accrue to institutional players with capital and co‑location privileges, and bots cannot rescue an inherently bad strategy.

Manual vs algorithmic execution: a structural comparison

The operational gap between manual and automated trading is widening across several dimensions. In terms of speed and latency, manual traders execute through user interfaces with latency measured in seconds or minutes, while algorithmic systems operate in microseconds via co‑located servers. Emotional discipline is another divide: human traders are subject to fear and greed, with panic sell‑offs common, whereas bots execute pre‑defined rules and reduce panic selling by 47%. Availability compounds the problem further, since traders need sleep but crypto markets never close, and bots operate around the clock without interruption. On accessibility, manual trading apps remain widely available with a low barrier to entry, but AI‑driven tools still often require coding knowledge or access to bot platforms, and retail bots face higher fees and slower infrastructure that limit profitability.

One unresolved tension in this space is that many algorithmic tools remain institutionally shaped even when marketed to individual users. OneBullEx’s architectural response is to collapse the gap between research capability and interface usability. OneALPHA makes strategy research accessible through natural language input, while the platform’s integrated validation pipeline (walk-forward optimization, forensic performance breakdowns, glass-box code visibility) provides the kind of rigour typically associated with institutional-grade research workflows.

Risks, regulatory responses and hidden challenges

Even as AI improves efficiency, it introduces new risks. The 2010 Flash Crash showed how algorithmic feedback loops can destabilise markets. Wharton researchers warn that AI trading agents could collude without explicit coordination: algorithms might punish competitors who undercut prices or adopt similar learning biases, leading to higher prices and reduced market liquidity.

Regulators are responding. The U.S. Commodity Futures Trading Commission (CFTC) issued a request for comment in January 2024 asking how AI impedes anti‑fraud enforcement and whether current rules adequately address algorithmic manipulation. Commissioner Kristin Johnson proposed surveys of AI use and heightened penalties for AI‑driven misconduct. The CFTC’s Technology Advisory Committee recommended transparency around black‑box algorithms and adoption of AI risk‑management frameworks aligned with the U.S. National Institute of Standards and Technology (NIST) guidelines.

If AI-native markets are to scale responsibly, automation needs to be supported by transparency, integrity, and auditable performance. OneBullEx reflects that direction through an architecture built around validated research pipelines, fair NAV-based accounting, visible performance histories, and a glass-box approach to strategy code generation that contrasts with the opaque models drawing increasing regulatory scrutiny.

Conclusion

The structural evolution of crypto futures is happening at the infrastructure level. As algorithmic participation grows and regulators push for greater transparency, the architecture of exchanges matters more than it used to. OneBullEx’s approach, embedding quantitative research tools and systematic execution pipelines directly into the exchange, offers one model for how that architecture can evolve.

About OneBullEx

OneBullEx is a next-generation derivatives trading platform offering USDT-settled perpetual futures, automated trading systems, and secure infrastructure for global users. Powered by OneMore Group, OneBullEx combines institutional-grade oversight with cutting-edge trading technology to provide a stable, transparent, and efficient environment for traders worldwide.

 

Best Mart 360 Announces 2025 Annual Results

By
Advertorial Desk
-

Recorded Continuous Growth in Revenue, Proposed a final dividend of HK9.0 cents per share


Highlights:

  • Revenue increased by 2.2% to approximately HK$2,867.7 million.
  • Gross profit increased by 0.7% to approximately HK$1,035.1 million.
  • Profit attributable to owners of the Company recorded approximately HK$219.7 million.
  • As at 31 December 2025, the Group operated a total of 183 chain retail stores (2024: 176), including 178 retail stores in Hong Kong and 5 retail stores in Macau.
  • Basic earnings per share was approximately HK22.0 cents. The Board recommended the payment of final dividend of HK9.0 cents per share.

Financial Highlights:

HK$’000

Year ended

31 Dec 2025

Year ended

31 Dec 2024

(Restated)

Change
Revenue 2,867,695 2,805,146 +2.2%
Gross profit 1,035,074 1,027,997 +0.7%
Gross profit margin 36.1% 36.6% -0.5 p.p.
Profit attributable to owners of

the Company

219,730

245,901

-10.6%

HONG KONG SAR – Media OutReach Newswire – 27 March 2026 – Best Mart 360 Holdings Limited (“Best Mart 360” or the “Company”, together with its subsidiaries, the “Group”; stock code: 2360.HK), a leisure food retailer in Hong Kong, announced its results for the year ended 31 December 2025. During the year, the revenue recorded by the Group amounted to approximately HK$2,867,695,000 (2024: HK$2,805,146,000), representing an increase of approximately 2.2%.

During the Financial Year under Review, gross profit was approximately HK$1,035,074,000 (2024: HK$1,027,997,000), representing an increase of 0.7%. The Group’s gross profit margin for the year was approximately 36.1%, compared to approximately 36.6% in 2024. This contraction in margin was primarily attributable to the strategic implementation of enhanced promotional campaigns designed to navigate the ongoing trend of consumption downgrading and intensified market competition.

Profit attributable to owners of the Company for the year was approximately HK$219,730,000 (2024 (Restated): approximately HK$245,901,000), primarily due to a slight reduction in average revenue per store and a contraction in gross profit margin, which collectively impacted overall profitability. The net profit margin (before interest and tax) moderated to approximately 9.8%, down from approximately 11.2% for the year ended 31 December 2024 (Restated).

For the Financial Year under Review, basic earnings per share was approximately HK22.0 cents. The Board recommended the payment of final dividend of HK9.0 cents per share.

BUSINESS REVIEW
Strategy Adjustment & Opened 10New Retail Stores
As at 31 December 2025, the Group operated a total of 183 chain retail stores, including 178 chain retail stores (31 December 2024: 170 stores) in Hong Kong and 5 chain retail stores (31 December 2024: 6 stores) in Macau respectively. During the Financial Year under Review, the Group opened 10 new retail stores and closed 3 stores upon expiration of their respective lease terms in alignment with the Group’s strategy adjustment.

The ratio of rental expense (cash basis) to sales revenue of retail stores for the year ended 31 December 2025 was approximately 9.6%, which was similar to that of approximately 9.6% for the year ended 31 December 2024.

Introduced Popular Brands & Launched on Grocery Delivery Platform
Hong Kong residents’ growing propensity to spend in Mainland China, coupled with inbound visitors’ preference for in-depth experiences, more rational and prudent consumption patterns, as well as the intensified competition in the local market from Mainland China e-commerce players leveraging economies of scale, the Hong Kong retail market is undergoing a structural long-term transformation, with the industry’s competitive landscape and consumption behaviour being reshaped.

In response to the challenging business environment, the Group adopted a series of timely and targeted measures to navigate these difficulties. These included optimizing product mix and strengthening the offering of basic foodstuffs covering cereals, noodles, canned food, milk, chilled and frozen food, daily necessities as well as basic groceries. The Group also introduced popular Mainland brands as well as imported a wide range of specialty food from around the world to meet the needs and expectations of local consumers and visiting tourists. To further strengthen its business, the Group launched on the Foodpanda grocery delivery platform during 2025 to expand its online sales channels, and rolled out a variety of promotional initiatives including shopping vouchers. These initiatives collectively contributed to the Group’s sales growth during the Financial Year under Review.

The Group procured quality products from overseas suppliers as well as brand owners or importers in Hong Kong. For the year ended 31 December 2025, the Group offered a total of approximately 3,425 stock keeping units (“SKU”) of products (for the year ended 31 December 2024: approximately 3,653 SKU) from suppliers principally from (but not limited to) Japan, Mainland China, Europe, Vietnam, Korea, the United States and other Asia-Pacific countries.

The Group sourced the most popular and trendy food products from various regions, striving to provide customers with diverse, multi-brand, and multi-category global product choices.

As at 31 December 2025, the total amount of inventories of the Group amounted to approximately HK$316,841,000 (31 December 2024: approximately HK$339,513,000), representing a decrease of approximately 6.7% year-on-year. The decrease in the Group’s total inventories was mainly attributable to optimised inventory management and the timing shift of the Lunar New Year holiday from January to February.

During the Financial Year under Review, the Group continued to actively develop private label products that on one hand allowed the Group to capture pricing advantages and exercise a higher level of quality control over its products and on the other hand further uplift its brand awareness and strengthen customers’ loyalty. For the Financial Year under Review, sales derived from private label products were approximately HK$520,821,000 (for the year ended 31 December 2024: approximately HK$477,222,000), accounted for approximately 18.2% of the Group’s revenue for the Financial Year under Review (for the year ended 31 December 2024: approximately 17.0%).

Expanded Customer Base & Enhanced Loyalty
To further deepen customer stickiness and broaden customers coverage, the Group used big data analysis and reformulated its marketing strategy to launch a new three-tier membership scheme and a second-generation mobile app in mid-June 2020. The new membership scheme helps to elevate brand positioning and market recognition, and the membership rewards have been fully optimised and enhanced, with more member benefits such as stamp reward for multiple-item purchase, special offers for selected products and access to the latest market information. During the Financial Year under Review, the number of the Group’s members increased from approximately 2,280,418 as at 31 December 2024 to approximately 2,395,862 as at 31 December 2025, representing an increase of approximately 5.1%.

The Group launched various marketing and promotional activities during the Financial Year under Review including the “Best Price” promotional campaign, which provided customers with a series of special offers for selected quality products from time to time to enhance customer loyalty. Meanwhile, the Group continued to advertise through television, newspapers, social media platforms and other media, which successfully attracted new customers encouraged repeat purchases and significantly enhanced market awareness of the Group.

PROSPECTS
Looking ahead, uncertainties in Sino-US relations, geopolitical risks and other factors will introduce further variables to economic recovery, and economic growth in Hong Kong and globally is expected to remain under pressure. The Board anticipates that the retail sector in Hong Kong will remain challenging in the near term. Nevertheless, the Group will continue to operate in a cautiously optimistic manner, closely monitor the development of various adverse factors that may impact the Group’s performance, and timely implement necessary and appropriate measures through refined operations and management to adapt to the ever-changing market environment.

The Group will continue to prioritize the Hong Kong market as its core focus, optimize its product mix and enhance the development of its private label products, with a wider range of staple foods and necessities to better meet consumer demand and enhance the Group’s competitiveness in the retail market.

To maintain sound operational efficiency, the Group will timely review the regional distribution of its brand stores, implement a moderate expansion policy and flexible leasing strategies, and actively pursue suitable opportunities to expand the retail network for its core retail brand “Best Mart 360º” and global gourmet brand “FoodVille” in Hong Kong and Macau, targeting a net increase of 10 retail stores annually under its dual-brand model, catering to the diverse needs of different customer segments for quality food products.

Mr. Hui Chi Kwan, Chief Executive Officer of the Group, said, “Faced with an increasingly complex operating environment, the Group will maintain a prudent and pragmatic approach in its operations and continue to work closely with its employees, customers and other stakeholders, striving to improve business performance and deliver stable returns to shareholders.”

Hashtag: #BestMart360 #優品360 #AnnualResults #業績 #全年業績

The issuer is solely responsible for the content of this announcement.

Best Mart 360 Holdings Limited

Best Mart 360 Holdings Limited operates chain retail stores under the brand “Best Mart 360˚”, offering wide selection of imported and pre-packaged leisure foods and other grocery products principally from overseas. It is the Group’s business objective to offer “Best Quality” and “Best Price” products to customers through continuous efforts on global procurement with a mission to provide comfortable shopping environment and pleasurable shopping experience to customers. As at 31 December 2025, the Group operated a total of 183 chain retail stores, spanning all of the 18 districts in Hong Kong and strategic locations with heavy pedestrian flow in Macau. Among the chain retail stores, the global gourmet brand “FoodVille” launched in September 2021 is also included, targeting the medium-to-high-end-market.

Better by MTA Expands Its Global Elite Network with Distinguished New Platinum Members

By
Advertorial Desk
-

PALM BEACH GARDENS, Fla., March 27, 2026 /PRNewswire/ — Better by MTA, the premier global platform connecting medical travelers with trusted facilitators and accredited healthcare providers, proudly announces the addition of distinguished new Platinum Members. These leaders in international hospital care, ophthalmology, aesthetic surgery, and healthcare facilitation further elevate the platform’s commitment to quality, innovation, and seamless patient experiences worldwide.

The newest Platinum Members include:

King Faisal Specialist Hospital & Research Centre (KFSH)

At King Faisal Specialist Hospital & Research Centre (KFSH), international patients from around the world are welcomed with compassionate, personalized, and innovative medical care. Through its International Healthcare Services, the hospital is dedicated to guiding patients through every step of their healthcare journey—ensuring comfort, clarity, and confidence from the first inquiry through full recovery.

The mission of KFSH is to deliver exceptional, personalized healthcare to international patients by connecting them with world-renowned specialists and advanced facilities while ensuring a seamless, comfortable, and stress-free experience. Its vision is to be the preferred global destination for international healthcare, recognized for advanced medical technologies, patient-centered care, and pioneering research.

Supporting this mission is an internationally certified team focused on providing a smooth and supportive experience for patients and their families. Certified Medical Travel Professionals manage the details of the care journey, while medical liaisons and case managers facilitate clear and continuous communication between patients, healthcare providers, and referring physicians. Multilingual support staff provide culturally sensitive assistance in patients’ preferred languages, ensuring clear communication and personalized support throughout the treatment process.

FV Hospital – Vietnam

FV Hospital is a private hospital, wholly foreign-owned, established by a collective of French physicians led by Dr Jean-Marcel Guillon. The hospital formally opened its doors on April 11, 2003. In 2024, FV became a member of Thomson Medical Group – one of South-East Asia’s leading healthcare providers, which has its headquarters in Singapore.

FV was the first hospital in the region to receive HAS certification (Haute Autorité de Santé) from the French National Authority for Health since 2007. It is also the only hospital in Southern Vietnam to have achieved JCI international accreditation four consecutive times, from 2016 to 2025. These prestigious international certifications reflect FV Hospital’s commitment to patient safety and internationally recognized standards of care.

FV currently employs 1,500 staff, including more than 200 doctors from Vietnam, France, Germany, and several other countries. Operating twenty-four hours a day, FV provides a full range of medical services across more than 45 specialties. Over more than two decades, FV has served over six million patient visits, including well over a million international patients from more than 170 countries.

With the ambition of becoming a leading healthcare provider in Asia, FV offers direct billing with over 100 insurance companies and accepts Vietnam’s national health insurance scheme, alongside a range of other financial support options. As a result, patients can access internationally accredited healthcare at approximately 50% of the cost of comparable hospitals in the region.

Dr. Isaac Hindi

American British Cowdray Medical Center (ABC), Santa Fe Campus – Mexico

Dr. Isaac Hindi is a highly respected ophthalmologist specializing in Cornea, Cataract, and Refractive Surgery at the American British Cowdray Medical Center (ABC) – Santa Fe Campus in Mexico City. ABC Medical Center has been recognized by Newsweek as one of the World’s Best Hospitals 2024 and is widely regarded as the most prestigious private hospital in Mexico.

Board-certified by the Mexican Board of Ophthalmology and the International Council of Ophthalmology (ICO), Dr. Hindi has completed advanced international fellowship training in Cornea and Refractive Surgery, with further specialized programs in Israel and Latin America.

ABC Medical Center is Joint Commission International (JCI) accredited and Magnet® recognized by the American Nurses Credentialing Center (ANCC), distinctions reflecting the highest standards in global healthcare quality, safety, and patient-centered care. For over 14 consecutive years, both ABC campuses have maintained JCI accreditation, underscoring their unwavering commitment to international excellence.

Dr. Hindi offers comprehensive ophthalmology services including advanced cataract surgery, corneal transplantation, glaucoma management and surgery, retinal treatments, ICL surgery, intracorneal ring implantation, and refractive procedures. Services are available in English, Spanish, and Hebrew.

Dr. Patrick Tonnard, MD, PhD

CEO & Founder, Coupure Center for Plastic Surgery & Aesthetic Medical Center 2 (EMC²) – Ghent, Belgium

Dr. Patrick Tonnard is a world-renowned, board-certified plastic and reconstructive surgeon recognized globally as a pioneer in facial rejuvenation. As CEO and Founder of the Coupure Center for Plastic Surgery and EMC² in Belgium, he leads two of Europe’s most respected aesthetic institutions.

Dr. Tonnard is the creator of groundbreaking techniques including the MACS-lift and nanofat grafting, innovations that have transformed global standards for natural, minimally invasive facial rejuvenation. His regenerative approach integrates advanced surgical techniques with stem-cell-based fat grafting methods, delivering results that look natural and endure for 10–15 years.

With more than 100 peer-reviewed scientific publications, over 250 international lectures and live surgical demonstrations, and seven published books, Dr. Tonnard combines clinical mastery with academic leadership. His practice is especially recognized for natural facial rejuvenation and specialized male facial aesthetics, offering patients refined outcomes that restore vitality while preserving individuality.

Emerge Medical Travel

Emerge Medical Travel is a reliable healthcare facilitation platform that links patients from all over the world with AACI-accredited hospitals and well-known Indian medical professionals. Our mission is to create smooth, customized medical journeys that are guided by compassion, safety, and clarity at every stage.

The outstanding patient experience is at the core of our philosophy. Beyond medical care, we make sure each person has a comfortable healing environment, seamless coordination, and substantial support.

Emerge incorporates the Better App, a digital tool that streamlines patient-hospital communication, document sharing, and treatment coordination, in collaboration with the Medical Tourism Association (MTA). This improved system raises the standard of care for patients worldwide, increases transparency, and fosters trust.

Emerge Medical Travel empowers patients to get top-notch healthcare by combining clinical excellence, compassionate service, as well as innovative technologies. The company is driven by a commitment to quality and integrity.

Strengthening the Global Medical Travel Ecosystem

The addition of these Platinum Members reinforces Better by MTA’s mission to build a trusted, technology-driven ecosystem that connects patients with vetted providers and facilitators who meet the highest international standards.

Jonathan Edelheit, CEO of the Medical Tourism Association, stated:

“Better by MTA was created to bring greater transparency, quality, and coordination to the global medical travel industry. Welcoming these new Platinum Members further strengthens our network of world-class providers and facilitators committed to patient safety, innovation, and excellence. These leaders exemplify the level of quality and professionalism that medical travelers deserve.”

As global demand for cross-border healthcare continues to grow, Better by MTA remains at the forefront of advancing trust, technology integration, and patient-centered solutions worldwide.

About Better by MTA

Better by MTA is a global platform that bridges the key players in the medical tourism ecosystem, connecting medical travelers, qualified facilitators, and accredited providers to drive a seamless medical travel process. Better provides access to trusted providers, robust education, financing options, and unparalleled quality care, improving the medical travel experience.

To learn more, visit better.medicaltourism.com.

TCL Electronics (01070.HK) Achieving High-Quality Global Growth in 2025, with Adjusted Profit Attributable to Owners of the Parent and Dividends Surging by over 56%

By
Advertorial Desk
-

Results Highlights

  • Leveraging the dual-drive strategy of “Globalisation” and “Mid-to-High-End”, TCL Electronics has achieved quality growth in global business and continuously strengthened overall profitability. In 2025, the Company’s revenue increased by 15.4% year-on-year (YoY) to HK$114.58 billion, profit after tax increased by 36.7% YoY to HK$2.53 billion, and adjusted profit attributable to owners of the parent increased by 56.5% to HK$2.51 billion compared with the previous year.
  • In 2025, TCL TV’s shipment ranking consistently remained at the second position among global branded TVs [1]; TCL Mini LED TV global shipment surged by 118.0% YoY, with its scale consistently ranking the first globally [2]. The continuous advancement of the “Mid-to-High-End” strategy has driven the gross profit margin of the large-sized display business to increase by 1.3 percentage points YoY to 16.8% during the year.
  • The internet business sustained high profitability. In 2025, internet business revenue increased by 18.3% YoY to HK$3.11 billion, with a gross profit margin as high as 56.4%. The Company’s overseas flagship models were among the first in the industry to integrate Google Gemini. As at the end of 2025, TCL Channel’s global cumulative user base exceeded 45.70 million, with commercialisation and monetisation capabilities significantly strengthened.
  • The innovative business continued to expand in scale, with revenue in 2025 surging by 31.9% YoY to HK$35.63 billion. Among these, the photovoltaic business revenue increased by 63.6% YoY to HK$21.06 billion, demonstrating outstanding market competitiveness and development resilience.
  • The Board proposed a final cash dividend of HK49.80 cents per share for 2025, with a dividend payout ratio of approximately 50% of adjusted profit attributable to owners of the parent.

HONG KONG, March 27, 2026 /PRNewswire/ — TCL Electronics Holdings Limited (“TCL Electronics” or the “Company”, 01070.HK) today announced its annual results for the year ended 31 December 2025. In 2025, the Company continued to make breakthroughs in product mix, technological leadership and quality enhancement, achieving healthy growth in business scale. During the year, the Company achieved revenue of HK$114.58 billion, representing a YoY increase of 15.4%, and its gross profit reached HK$17.90 billion, representing a YoY increase of 15.1%.

The Company continued to strengthen the building of various core capabilities, fully introduced AI applications across R&D, manufacturing, supply chain and sales, and comprehensively enhancing operational efficiency, with the overall expense[3] ratio decreasing by 0.7 percentage points YoY to 11.1%. In 2025, the Company achieved continuous improvement in internal operational efficiency and its overall profitability continued to be optimised. Its profit after tax increased by 36.7% YoY to HK$2.53 billion, and adjusted profit attributable to owners of the parent reached HK$2.51 billion, representing an increase of 56.5% compared with HK$1.61 billion of the previous year.

To reward Shareholders for their long-term support and share development results, the Board proposed a final cash dividend of HK49.80 cents per share for 2025, with a dividend payout ratio of approximately 50% of adjusted profit attributable to owners of the parent. The final dividend per share increased significantly by 56.6% as compared with the previous year.

Mid-to-high-end display products and international market becoming core growth drivers, with TCL Mini LED TV maintaining global No. 1 position

Benefitting from effective enhancement of brand influence, efficient expansion of global channels and continuous optimisation of product mix, the Company’s display business revenue in 2025 increased by 9.2% YoY to HK$75.80 billion, gross profit increased by 16.4% YoY to HK$12.48 billion, and gross profit margin increased by 1.1 percentage points YoY to 16.5%.

The large-sized display business achieved revenue of HK$64.71 billion during the year, representing a YoY increase of 7.7%; gross profit reached HK$10.90 billion, representing a YoY increase of 17.2%, with gross profit margin increasing by 1.3 percentage points YoY to 16.8%. In 2025, TCL TV’s global shipment market share reached 14.7%, representing a YoY increase of 0.8 percentage points, consistently ranking second globally[4]; TCL Mini LED TV global shipment surged by 118.0% YoY, with shipment proportion increasing by 6.8 percentage points YoY to 13.0%, and shipment market share reaching 31.1%, ranking firmly at the first position globally[5], demonstrating the Company’s technological leadership and market competitiveness in the high-end display segment.

In terms of the international market, the large-sized display business’ revenue reached HK$47.50 billion, representing a YoY increase of 15.7%, with gross profit increasing by 29.4% YoY to HK$7.17 billion. The large-screen trend in the international market continued to accelerate, with overseas shipment of 65-inch and above TCL TVs surging by 50.0% YoY and shipment proportion increasing by 6.7 percentage points YoY to 24.2%; shipment of TCL Mini LED TV in the international market surged by as much as 228.0% YoY, with shipment proportion increasing by 7.1 percentage points to 10.6%. Benefitting from the optimisation of product mix, the gross profit margin from the international market increased by 1.6 percentage points YoY to 15.1%, with the premiumisation strategy delivering remarkable results. In the European market, the Company achieved full coverage of key channels, driving revenue increased by 13.9% YoY. The product mix shifted towards higher value and higher gross profit margin. In the North American market, the Company successfully implemented the “Mid-to-High-End” strategy, achieving dual improvement in revenue and ASP. During the year, the revenue increased by 11.2% YoY, while ASP recorded an over 20% YoY increase. In emerging markets such as Latin America, the Middle East and Africa, and Asia-Pacific, the Company actively promoted localised operations and continued to advance the dual-track strategy of synergistic development between offline channels and e-commerce platforms, driving a 19.8% YoY increase in TCL TV revenue and effectively unleashing the potential for scale growth. In 2025, TCL TV ranked among the top 3[6] in terms of retail sales volume in over 20 countries worldwide.

In terms of the PRC market, while the overall industry shipment volume declined due to weak consumer demand, the Company’s large-sized display business achieved steady gains in market share against the market headwind, supported by the “Mid-to-High-End” strategy. During the year, the Company’s core high-end products delivered outstanding performance. Among them, TCL Mini LED TV shipment increased by 33.6% YoY, with shipment proportion increasing by 7.2 percentage points YoY to 22.5%; TCL QLED TV shipment increased by 29.6% YoY with shipment proportion increasing by 6.4 percentage points YoY to 21.2%. The high-end product portfolio continued to expand. Product mix upgrades further deepened the large-screen and mid-to-high end trends. The mid-to-high end trend also made the large-screen trend more prominent. The shipment proportion of 65-inch and above TCL TVs in the PRC market rose to 57.6% in 2025, with the average size increasing to 64.3 inches. The significant improvement in product mix drove the overall gross profit margin to increase by 1.9 percentage points YoY to 21.7%, with significant improvement in profitability and steady enhancement in operational quality.

During the year, the small-and-medium-sized display business adhered to the strategy of “prioritising efficiency and focusing on key markets”, deeply cultivated tier-one network carrier channels in Europe and North America, and consolidated strategic relationships with core partners, achieving steady development. In 2025, revenue of the Company’s small-and-medium-sized display business increased by 17.8% YoY to HK$9.97 billion, with gross profit increasing by 10.4% YoY to HK$1.44 billion.

In addition, the Company’s smart commercial display business leveraged the globally leading resource advantages of its TV business, and focused on four major scenarios of office, retail, catering business and exhibition, thus continuously enhancing product competitiveness. In 2025, revenue of the smart commercial display business increased by 28.4% YoY to HK$1.12 billion, with gross profit increasing by 24.0% YoY to HK$0.14 billion.

Deepening collaboration with global giants and driving TV interaction and upgrade through AI to achieve growth in both revenue and profit for internet business

TCL Electronics continuously seized global new opportunities arising from AI technology development and deeply cultivated the global home internet sector, placing users at the core, strengthening the construction of AI and content ecosystems, and continuously enhancing user experience. During the year, the Company’s internet business achieved simultaneous improvement in business scale and profitability quality, with revenue increasing by 18.3% YoY to HK$3.11 billion, gross profit increasing by 18.8% YoY to HK$1.75 billion, and gross profit margin standing at 56.4%, maintaining strong profitability.

In the international market, TCL Electronics continued to deepen strategic cooperation with international giants such as Google, Roku and Netflix, with flagship models pioneering the industry to integrate Google Gemini, and upgraded the AI interactive experience, whilst completing a comprehensive upgrade of its content aggregation application, TCL Channel. The proportion of local premium content doubled, driving a substantial YoY increase of 150.0% in average daily total usage duration. By the end of 2025, TCL Channel’s global cumulative users exceeded 45.70 million, with content appeal and commercialisation and monetisation capabilities significantly strengthened, further solidifying the leading advantages in the global home internet business.

In the domestic market, leveraging its proprietary OTT smart device operating platform, the Company focused on AI content generation and interactive experience upgrades. In terms of product innovation, the Company focused on upgrading AI technology on the TV front to deliver an even more immersive interactive experience. Meanwhile, the Company created a proprietary copyright “Content Factory” through AI, achieved large-scaled implementation of AI-generated content in the children’s segment, and improved AI-generated animation creation efficiency through self-developed tool Agent. The AI hardware product Amby Uni was successfully launched to the market. During the year, the Company continuously optimised the business structure and consolidated its leading position in the global home internet sector.

Driving high-quality growth of photovoltaic business through the asset-light operating model while building long-term competitive advantages via diversified AI layout

By consistently increasing R&D investment, the Company focused on AI technology to cultivate its second growth curve. By leveraging the enhancement of global marketing and brand influence, the innovative businesses achieved continuous expansion during the year, with revenue surging by 31.9% YoY to HK$35.63 billion in 2025.

The photovoltaic business adhered to a relatively asset-light approach in the domestic market. It developed market-based electricity trading capabilities, strengthened channel partnerships, and steadily enhanced operational efficiency and competitiveness, entering a phase of high-quality development. The overseas business focused on key European countries, leveraged SunPower to enhance brand synergy, and accelerated the “solar-storage-heating” product layout and business expansion. In 2025, the photovoltaic business’ revenue increased by 63.6% YoY to HK$21.06 billion, with gross profit increasing by 47.5% to HK$1.81 billion. In 2025, the photovoltaic business achieved new installed capacity of 8.0 GW domestically and cumulatively contracted over 340 industrial and commercial projects, with cumulative dealer channels exceeding 2,530 and contracted rural households totaling nearly 360,000.

In the AR/XR sector, RayNeo, incubated by the Company, continued to maintain its industry-leading position. In 2025, RayNeo held a 32% market share in the PRC AI/AR glasses market, ranking first with an absolute advantage[7]; in the PRC AR glasses online market in 2025, RayNeo held a 35.4% sales volume share, maintaining rapid growth amid intensifying market competition, and ranking first in the PRC online omni-channel market for four consecutive years[8]. In terms of product innovation, the Company launched in October 2025 the world’s first HDR glasses, RayNeo Air 4, integrating seven major technological highlights and leading industry technology development. At CES 2025, the Company launched TCL AiMe, the world’s first modular AI companion robot, perfectly integrating AI technology, IoT control and home companionship functions. As the smart home ecosystem matures, innovative products such as TCL AiMe are expected to become widely seen in future homes, demonstrating enormous market potential.

Future Outlook: Driving industrial upgrade through AI, focusing on dual enhancement of profitability and scale, and achieving high-quality development

Looking ahead, the Company will continue to uphold the business philosophy of “Strategy Guidance, Innovation Driven, Advanced Manufacturing and Global Operation”. The core business will adhere to the dual-drive strategy of “Globalisation” and “Mid-to-High-End”, while new business segments will take AI innovation and digital intelligence empowerment as key drivers. The Company is committed to continuously expanding its global scale, improving profitability, and achieving high-quality sustainable development. In terms of Shareholder return, the Company attaches great importance to the long-term value of Shareholders. Going forward, while maintaining sound business growth, the Company will continuously optimise its capital structure, aiming to deliver sustainable, high-quality and long-term returns to Shareholders through solid performance.

[1] Source: Global brand TV shipment of 2025 from Omdia.

[2] Source: Global brand Mini LED TV shipment of 2025 from Omdia.

[3] Overall expenses include selling and distribution expenses and administrative expenses.

[4] Source: Global brand TV shipment of 2025 from Omdia.

[5] Source: Global brand Mini LED TV shipment of 2025 from Omdia.

[6] Source: Circana (for the U.S. market) and the Company’s internal reports (for other markets), based on TV retail sales volume of 2025.   

[7] Source: CINNO Research, sales volume data of consumer-grade AI/AR market in China for 2025.

[8]  Source: RUNTO, brand sales volume share data of the online AR glasses market in China for 2025.

About TCL Electronics

TCL Electronics Holdings Limited (01070.HK, incorporated in the Cayman Islands with limited liability) has been listed on the Main Board of The Stock Exchange of Hong Kong Limited since November 1999. Its business scope covers display business, innovative business, and internet business. Guided by the business philosophy of “Strategy Guidance, Innovation Driven, Advanced Manufacturing and Global Operation”, TCL Electronics actively embraces transformation and innovation and focuses on breaking into the mid-to-high-end global market, and strives to the all-category layout for the “Smart IoT Ecosystem”. Dedicated to providing users with all-scenario smart healthy living experiences, TCL Electronics aims to become a leading global intelligent terminal enterprise. TCL Electronics is included in the list of eligible shares for Shenzhen-Hong Kong Stock Connect. It is a constituent stock of the Hang Seng Stock Connect Hong Kong Index, the Hang Seng Composite LargeCap & MidCap Index, and the Hang Seng Composite MidCap Index. Since 2018, the Company has been awarded an ESG rating of A by Hang Seng Indexes Company for several consecutive years.

For more information, please visit TCL Electronics’ investor relations website at http://electronics.tcl.com, or access the official WeChat account of TCL Electronics Investor Relations.

 

SOCO® Group to Showcase Sludge Solidification Solutions at NASTT No-Dig Show 2026

By
Advertorial Desk
-

PALM SPRINGS, Calif., March 27, 2026 /PRNewswire/ — SOCO® Group (“SOCO®” or “the Company”), a technology-driven manufacturer specializing in water absorbing and retaining solutions for agricultural and industrial applications, will showcase sludge solidification and waterproofing solutions at Booth 676 of the NASTT No-Dig Show 2026 from March 29 to April 2. As utilities, municipalities, and contractors seek more efficient and environmentally responsible approaches to underground infrastructure work, the Company will highlight technologies designed to reduce liquid waste volume, improve handling efficiency, and support more controlled construction processes across trenchless and related infrastructure applications.  

SLUSORB was used in different application
SLUSORB was used in different application

SOCO®‘s presence will mark its first appearance at the show and reflects a broader push to bring application-specific sludge management solutions to major trenchless markets, including the United States. SOCO®‘s focus for the event will center on how polymer-based solidification technologies can help address recurring operational and compliance challenges in scenarios such as horizontal directional drilling (HDD), no-dig drilling, tunneling, leachate treatment, and other liquid slurry environments. 

“Trenchless construction is often evaluated by equipment, access, and installation method, but material control is just as important to project execution. When slurry and sludge handling are not managed efficiently, costs rise, transport becomes more complex, and environmental risk increases,” Jessie, Manager director with SOCO® commented. “Our focus is to help customers solve that part of the equation in a way that is practical, scalable, and suited to real jobsite conditions.”

SOCO® will highlight its sludge solidification solution as part of an integrated approach covering the full wastewater sludge process from generation to final disposal. The Company is framing solidification as an operational tool that can help simplify the movement of waste streams, reduce leakage risk, and improve downstream disposal efficiency across the disposal process. That matters in trenchless and underground infrastructure work, where liquid waste handling can quickly affect timelines, logistics, and total project cost.

SLUSORB, a polymer solution developed to capture and lock free liquid in sludge and slurry, is at the center of the showcase. SLUSORB is used to help waste meet the Paint Filter Test for no free liquid while also supporting lower dosage requirements, high solidification efficiency, and transportation savings. The material features a low curing expansion rate of approximately 1%, helping reduce handling complexity and optimize transportation costs. Designed with environmental considerations in mind, SLUSORB is biodegradable and compliant with EPA 9095B standards. In addition, it provides effective dust suppression during application without posing harm to human health, contributing to safer jobsite conditions. The product is presented for use across tunnel projects, HDD, landfill leachate, mine sludge, and lagoon dredging, among other applications, where liquid waste must be stabilized before transport or landfill.

SLUSORB has shown considerable promise as a solution for managing landfill leachate, particularly in handling high-strength and concentrated waste streams. When applied to concentrated leachate or during transport and storage, SLUSORB rapidly absorbs free water, effectively reducing leachate volume and limiting fluid mobility. The gelation process minimizes the risk of leakage and uncontrolled dispersion, thus enhancing operational safety. Additionally, SLUSORB improves the efficiency of solidification and bolsters the structural integrity of the material. A key benefit is that the solidified leachate can be directly disposed of in the landfill (passing the paint filter test), eliminating the need for transport or external treatment while ensuring proper containment and environmental safety. This approach offers several practical benefits, including simpler handling, reduced treatment complexity, minimized environmental contamination, cost reduction, and the flexibility to address emergency or high-concentration leachate scenarios.

In trenchless and adjacent infrastructure work, customers are also under pressure to comply with environmental regulations, reduce hauling costs, and improve the long-term containment of pollutants. SOCO® is using NASTT to position its solutions around those priorities. Its regional strategy is focused on specific use cases over standard products. This is an application-driven approach built around real operating conditions and end-user needs. This also supports a broader industry conversation around responsible underground infrastructure management. Trenchless methods are often valued for limiting surface disruption, but project performance also depends on how effectively associated waste streams are handled.

By improving sludge solidification, moisture control, and waterproofing performance, SOCO aims to show how materials can support both execution efficiency and more environmentally conscious construction practices in the field.

For more information about SOCO® Group’s sludge solidification solutions, please visit https://www.socochem.com/waste-landfill-slurry-solidification.html. 

About SOCO® Group

Founded in 2009, SOCO® Group is a technology-driven manufacturer specializing in water-absorbing and retention solutions for agricultural and industrial applications. The company focuses on application-led research and development, developing customized solutions tailored to specific operating needs across industrial and infrastructure settings. Through continued product development and collaboration with global partners, SOCO® supports customers with solutions designed to improve water management, resource efficiency and project performance.

Name: Anna

Email: service@socochem.com

Business Phone: 0532-83886779

Whatsapp: +8618661680608

COINPAYMENTS accelerates APAC expansion with OSL Group partnership

By
Advertorial Desk
-

HONG KONG, March 27, 2026 /PRNewswire/ — COINPAYMENTS, a global leader in cryptocurrency payment processing, today announces a partnership with OSL Group (863.HK), Asia’s leading stablecoin trading and payment platform, as part of its strategic expansion in the region.

The partnership, announced ahead of the Japan Grand Prix this weekend, will provide COINPAYMENTS with access to OSL Group’s existing local payment rails and fiat off ramping capabilities, enabling it to offer its secure, compliant and seamless digital payment solutions to businesses across the region.

Partnering with a premier, public company underscores COINPAYMENTS’ commitment to regulatory excellence and institutional-grade service standards. By aligning with an established regional leader, COINPAYMENTS significantly accelerates its strategic growth objectives across Asia, tapping into OSL Group’s deep-rooted expertise and local market credibility.

“Partnering with OSL Group marks a pivotal milestone in our global expansion strategy,” said Ali Rafi, Group CEO of COINPAYMENTS, who will be meeting with APAC-based partners and customers at the Suzuka Circuit during the Japan F1 Grand Prix this weekend. “By combining our industry-leading payment gateway with OSL’s regulated infrastructure, we are bridging the gap between digital assets and traditional commerce in one of the world’s most dynamic financial hubs. We are excited to empower businesses across Asia to embrace the future of finance with the speed and confidence that the COINPAYMENTS brand is known for.”

As the demand for digital asset payment methods experiences an unprecedented boom across Asia, the partnership positions COINPAYMENTS for an exceptional year ahead, providing the scale and compliant infrastructure necessary to lead the next wave of digital commerce innovation in the region. It comes following the appointment of Alexander von Kaldenberg as Head of Strategic Partnerships for Asia, a further signal of COINPAYMENTS’ commitment to the market.

Alexander von Kaldenberg, Head of Strategic Partnerships Asia at COINPAYMENTS, said: “Asia is at the forefront of the digital asset revolution and our partnership with OSL Group allows us to meet this surging demand head-on. By leveraging OSL’s local, robust payment rails, we are removing the friction points for merchants looking to adopt crypto payments. This isn’t just about expansion; it’s about providing local businesses with the institutional-grade tools they need to thrive in a digital-first economy.”

The partnership builds on COINPAYMENTS’ longstanding relationship with Banxa, the global Web3 payment infrastructure provider, which was acquired by OSL Group in January 2026.

Eugene Cheung, Chief Commercial Officer of OSL Group, said “We are delighted to partner with COINPAYMENTS, a move that directly supports our commitment to enhancing global ease of access and seamless money movement. This collaboration highlights the strategic synergy following OSL’s acquisition of Banxa, and reinforces our commitment to closing the gap between global digital commerce and institutional grade financial services. We look forward to working alongside COINPAYMENTS as it enters a new phase of growth and innovation.”

About COINPAYMENTS
COINPAYMENTS is the global cryptocurrency payment gateway powering the future of digital commerce, enabling merchants to accept and settle digital assets globally to unlock growth and serve a new generation of consumers. Founded in 2013, the company has processed over $50 billion in crypto transactions, serving more than 250,000 merchants. COINPAYMENTS is a proud partner of the Aston Martin Aramco Formula One Team, bringing together two brands centred around trust, innovation, speed and high-performance.

Contact: coinpayments@mhpgroup.com

About OSL Group
OSL Group (HKEX: 863) is Asia’s leading stablecoin trading and payment platform that strives to provide compliant and efficient digital financial infrastructure services globally, empowering enterprises, financial institutions and individuals to seamlessly exchange, pay, trade, and settle between fiat and digital currencies. Grounded in the core values of Open, Secure, and Licensed, it is committed to building a more efficient ecosystem that connects global markets and enables instant, seamless and compliant value movement worldwide.

CIFF Guangzhou 2026: An Integrated Platform for Green, Intelligent and Collaborative Workspaces

By
Advertorial Desk
-

As global economies evolve and expectations for healthier, greener and more people-centred environments continue to rise, office and commercial spaces are entering a new phase of transformation. Sustainability is no longer only an environmental duty; it has become a strategic driver connecting ecological responsibility with business performance and social value.

GUANGZHOU, China, March 27, 2026 /PRNewswire/ — The Office & Commercial Space exhibition, held during Phase 2 of the 57th of CIFF Guangzhou (March 28–31, 2026) at the Canton Fair Complex, positions itself as a forward-looking platform shaping a new generation of sustainable and intelligent workplaces.

Guided by the theme CONNECT•CREATE, CIFF Guangzhou translates sustainability into concrete business opportunities, moving from principles to practical, large-scale applications. The exhibition builds a green office ecosystem across three key sectors — Office Environment, Office Seating and Public Commercial Space — offering an integrated vision that links materials innovation, product design and spatial solutions.

CIFF Guangzhou 2026. An Integrated Platform for Green, Intelligent and Collaborative Workspaces
CIFF Guangzhou 2026. An Integrated Platform for Green, Intelligent and Collaborative Workspaces

Office Environment: Building the Green Office Ecosystem

The office environment is transforming through hybrid work, increased focus on health and well-being, accelerating net-zero strategies and the growing role of office space as an expression of corporate culture. In response, the Office Environment Sector focuses on human-centred design, low-carbon development and digital integration, positioning the “Green Office” as a new benchmark.

Located in Area A, this sector serves as a full-chain platform for office trend release. It presents a comprehensive range of office furniture and supporting products, with particular emphasis on two high-growth areas: medical and senior care, and smart office solutions.

The healthcare and elderly care segment aligns with demographic trends and policies promoting the integration of medical services, elderly care and wellness, showcasing intelligent nursing beds, age-friendly furniture and integrated healthcare environments. Meanwhile, the smart office segment highlights the convergence of ergonomics and IoT technologies through solutions such as height-adjustable desks, health-focused seating and intelligent meeting systems, outlining new models for future office experiences. Brands such as Sunon, TIANTAN, VICTORY, QUAMA, SAOSEN, Jongtay, HONGYE, Kinwai, LOCTEK and COFEMO represent this ecosystem of sustainable, technology-driven innovation.

Office Seating: From Passive Support to Active Health

Office seating is shifting from passive posture correction to active physical adaptation, driven by advances in adaptive technology, dynamic support and breathable, eco-friendly materials. Office chairs are evolving beyond basic lumbar protection to become integrated health solutions combining biomechanics, materials science and intelligent technologies.

Located in Area D, the Office Seating Sector brings together leading international and domestic brands, guided by the dual values of health and originality and presenting innovative seating aligned with sustainable principles.

The sector showcases intelligent adaptive chairs, dynamic balance seating and environmentally friendly solutions, highlighting progress in ergonomics, scenario adaptation, intelligent interaction and sustainable design. These products reflect a new stage of development in which comfort, aesthetics and functional innovation converge toward greener, healthier and smarter office environments.

Brands such as KOKUYO, Lamex, HENGLIN, GTchair, ENOVA, Merryfair, Benithem and Bestuhl represent this ecosystem of innovation in healthy and sustainable seating.

Public Commercial Space: Sustainable Innovation for Complex Scenarios

Public and commercial spaces are changing rapidly due to functional complexity, invisible technological integration, renewed public space value and the growing importance of sustainability and resilience. Space design is shifting from a functional carrier to a composite ecosystem combining people-oriented design, technological empowerment and sustainable operation.

Located in Area B, the Public Commercial Space Sector presents solutions for schools, healthcare facilities, hotels, commercial complexes and transport hubs. Exhibits include modular rapid-installation systems, low-carbon materials, intelligent space management platforms and healthy environment control systems, promoting efficiency, resilience and human-centred design.

Brands such as LEADCOM, Hongji, Huimei, EDUNESTCO, Senchuan and New Century represent this ecosystem of innovative public space solutions.

Design-Driven Sustainability and Shared Value

In 2026, CIFF Luminous Path 2.0 expands its role as a flagship project embedding ESG principles into design, manufacturing and consumption. Its closed-loop approach—combining green design, low-carbon production and circular use—turns sustainability into an immersive experience for both visitors and exhibitors.

The exhibition is further enriched by themed platforms such as Linking Design Star, Design Art Culture and the Guangzhou Office Environment Theme Pavilion, which connect culture, business and innovation, showing how design can translate sustainability into market value while shaping future spatial narratives.

CIFF Office & Commercial Space aligns with China’s green development strategy by integrating low-carbon principles into booth construction, material selection and visitor experience, promoting sustainable lifestyles and encouraging a shift from awareness to action.

At the same time, CIFF reinforces its role as an industry connector, linking designers, distributors, public institutions and global buyers through initiatives such as CIFF Interbiz Club, international promotions and business matching, and building resilient, internationally connected value chains.

Standing at the intersection of industrial transformation and social responsibility, CIFF Guangzhou 2026 Office & Commercial Space defines a future where green is the foundation, intelligence is the engine and collaboration is the goal.

Join CIFF Guangzhou and discover how sustainability is reshaping the future of work and public space. www.ciff-gz.com

Uni-Bio Science Group Limited Announces 2025 Annual Results

By
Advertorial Desk
-

Record-Breaking Revenue of HK$586.2M and EPS Surged to HK$1.56 Cents

Dividends Distributed for Two Consecutive Years

Embarks on Innovation-Driven Transformation to Become a Global Pioneer in Regenerative Medicine


HONG KONG SAR – EQS Newswire – 27 March 2026 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2025 (the “Year”).

Key Accomplishments in 2025
During the Year, the Group achieved a spectrum of accomplishments, for both of its marketed products and innovative biologics. The key highlights include:

  1. During the Year, the Group delivered record-breaking financial results, with revenue recorded a 6.0% year-on-year (“YoY”) increase, reaching approximately HK$586.2 million. Profit for the year soared by 12.7% YoY to approximately HK$93.3 million, and net profit margin increased by 1.0 percentage points YoY to 15.9%, marking a historic high. The earnings per share reached approximately HK$1.56 cents, reflecting a growth of 15.5% YoY or a CAGR of 18.55% from 2023 to 2025.
  2. The Group generated solid cash from operations in the Year, operating cash flow and free cash flow increased by 32.7% and 27.3% YoY, respectively. Cash ratio increased from 0.53 times at the end of 2024 to 1.63 times at the end of 2025. The cash conversion cycle improved from 124 days to 107 days, highlighting greater operating efficiency. Backed by sustainable earnings and a healthy cash flow, the board of directors (“Board”) has declared a dividend payment for 2025 of HK$0.313 cents per share.
  3. Since its official launch in March 2024, Bogutai® has sustained strong growth momentum, driven by a solid commercialization strategy and successful academic engagement. In 2025, Bogutai® demonstrated rapid market adoption in China, achieving a remarkable year-on-year revenue growth of 111.0%.
  4. In May 2025, the Group’s second ophthalmology product, 金因康® (Diquafosol Sodium Eye Drops), received marketing approval from the China National Medical Products Administration (“NMPA”), marking a significant milestone in expanding the Group’s ophthalmic portfolio following GeneSoft®. The Group is actively preparing its launch and marketing strategy. In addition to leveraging synergy with GeneSoft® and its established online and offline distribution network for rapid market penetration, 金因康® will specifically target the mid-to-high-end segment of dry eye patients outside the hospital setting, those who prioritize long-term efficacy and premium product quality.
  5. In June 2025, the Group officially launched the high-end series GeneQueens® of 肌顏態® and the medical device brand 金因敷®, marking two key milestones in its strategic expansion into the integrated”Drug, Medical Device, and Aesthetics”field. These product launches reflect the Group’s commitment to enhancing its skin health product matrix and addressing evolving consumer needs for efficacy-driven, medical-grade skincare in both functional skincare and post-aesthetic recovery.
  6. In July 2025, the marketing application of Isavuconazonium sulfate capsules were officially accepted by the NMPA. Isavuconazonium sulfate capsules are expected to be approved for launch as early as the fourth quarter of 2026, offering a safer, more effective, and high-quality treatment option for patients suffering from invasive fungal infections.
  7. In 2025, the Group established a strategic partnership with Wenzhou Medical University to explore a thermosensitive gel formulation combining EGF and bFGF, leveraging the university’s proven expertise in bFGF production. As a key growth factor in regenerative medicine, bFGF is highly effective in promoting granulation and angiogenesis.
  8. Towards the end of 2025, the Group repositioned its long-term strategy from “Stable Growth” to “Innovation-Driven,” signifying a bold transformation from an integrated pharmaceutical company into a global pioneer in regenerative medicine. The Group is advancing a transformative R&D strategy spanning four key areas: muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration.

Annual Results
For 2025, the Group recorded a revenue of approximately HK$586.2 million, representing an increase of 6.0% YoY. Revenue from Bogutai® increased from approximately HK$ $63.5 million to approximately HK$ 134.0 million, representing a significant increase of 111.0%. Revenue generated from GeneTime® was approximately HK$220.4 million, representing an increase of 10.9% YoY. GeneSoft® recorded a 7.9% YoY decrease in revenue from approximately HK$41.9 million to approximately HK$38.6 million due to intense market competition. Pinup® recorded a decrease of 29.4% in revenue from approximately HK$244.2 million to approximately HK$172.5 million for the Year. In 2025, the Group adopted a more disciplined and selective hospital-supply strategy under volume-based procurement (VBP) to safeguard margins, particularly in regions where policy adjustments intensified price competition. At the same time, the Group accelerated diversification into pharmacy networks beyond traditional hospital channels and optimized its supply chain to improve cost and profitability. In 2024, Boshutai® was successfully included in the VBP by the Henan Seventeen Provinces Alliance and the procurement validity period is set for two years. Hospitals in many provinces began procuring Boshutai® in 2025. Following the destocking and a low base in 2024, revenue from Boshutai® increased from approximately HK$10.2 million to approximately HK$15.5 million, representing a significant increase of 51.9%. 肌顏態® generated approximately HK$2.8 million in revenue in its early stage. The limited revenue scale reflected several factors, including a relatively small number of products approved and launched during the Year, and the fact that specialized marketing and distribution teams were still being built and optimized.

Gross profit was approximately HK$487.6 million, representing an increase of 5.7% as compared with approximately HK$461.1 million in 2024, and gross profit margin increased by 0.2 percentage points YoY to 83.2%. The Group delivered another year of record-breaking profit, achieving approximately HK$93.3 million for the Year, representing an increase of 12.7% YoY. Net profit margin increased by 1.0 percentage points YoY to 15.9%. These results demonstrate the Group’s success in converting product innovation into market value through strong commercialization execution and financial discipline. The earnings per share reached approximately HK$1.56 cents, reflecting a growth of 15.5% YoY.

Prospects
Regenerative medicine has emerged as a rapidly developing field, focused on repairing, replacing, or regenerating damaged tissues or organs using cells, tissues, or genetic material. The sector has the potential to treat and address the underlying causes of chronic and advanced diseases. The global regenerative medicine market was approximately USD51.7 billion in 2025. It is projected to grow from USD63.0 billion in 2026 to USD555.6 billion by 2034, representing a compound annual growth rate (CAGR) of 31.3%. The increasing prevalence of chronic and hereditary diseases, together with rising healthcare expenditure in both developed and emerging markets, is expected to support continued growth in the regenerative medicine industry.

Mr. Kingsley Leung, Chairman of Uni-Bio Science, commented, “In 2025, we are proud to have delivered another year of record profitability, marking a significant milestone in our growth journey. During the year, we entered a new phase of strategic development. In anticipation of an increasingly favorable market environment, we advanced our strategic transition from ‘stable growth’ to ‘innovation-driven’ development, with a clear focus on four diversified therapeutic areas: musculoskeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration.

With multiple products progressing through our pipeline and accelerating toward commercialization, the Group has continued to broaden its marketing channels. In addition to strengthening our established offline hospital networks, deepening partnerships with local distributors, and hosting academic conferences, we have actively expanded into online e-commerce platforms to enhance product accessibility and extend our market reach. Our ambitions extend well beyond China. During the year, we formed a strategic partnership with Kexing Biopharm to accelerate the global expansion of Bogutai®. Through this collaboration, we have granted Kexing Biopharm exclusive commercialization rights for Bogutai® in six international markets—Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico—laying a solid foundation for global growth. We expect these markets to begin contributing revenue as early as the end of 2026. At the same time, we are advancing the FDA approval process for Bogutai® in the United States, aiming for approval as early as 2027.

In December, we also entered into a strategic collaboration with Wenzhou Medical University and the People’s Government of Ouhai District, Wenzhou, to foster a synergistic ‘government–university–enterprise’ model, further strengthening our capabilities in regenerative medicine. Supported by strong partnerships with local governments and leading academic institutions, we are well positioned to build a world-class biomedical ecosystem and enhance our end-to-end innovation capabilities.”
Hashtag: #Uni-BioScience

The issuer is solely responsible for the content of this announcement.

About Uni-Bio Science Group Limited

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2001 (Stock Code: 00690.HK). The Group is committed to powering the advancement of regenerative medicine with next-generation synthetic biology and complex peptide innovation. Focusing on four core research areas—muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration—the Group has built a diversified product pipeline encompassing innovative biologics, high-value generic drugs, and medical aesthetics. The Group operates GMP-compliant production bases in Beijing, Dongguan, and Shenzhen, with fully integrated capabilities spanning R&D, manufacturing, and commercial sales. Uni-Bio Science Group is dedicated to be the global leader in regenerative medicine, redefining how science restores and extends human life.

For further information, please contact:

1...739740741...6,552Page 740 of 6,552